Trials / Unknown
UnknownNCT00545961
Middle Meatal Bacteriology During Acute Respiratory Infection in Children
Clinical Relevance of Middle Meatal Bacteriology During Acute Respiratory Infection in Children - Randomised, Double-Blinded Clinical Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Oulu University Hospital · Academic / Other
- Sex
- All
- Age
- 6 Years – 13 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out whether the children with respiratory infection and the presence of pathogenic bacteria (S. pneumoniae, H. influenzae or M. catarrhalis) in the nasal middle meatus benefit from antimicrobial treatment.
Detailed description
Acute sinusitis is one of the most common disease in children requiring antimicrobial treatment. The diagnosis and treatment outcomes of acute sinusitis are contradictory, and better diagnostic criteria are needed. In adults with acute maxillary sinusitis, bacterial culture results obtained from the nasal middle meatus are comparable to those obtained from sinus puncture and aspiration. In children, the presence of pathogenic bacteria (S. pneumoniae, H. influenzae or M. catarrhalis) in the nasal middle meatus during respiratory infection predicts longer duration of signs and symptoms of common cold. In this randomized placebo-controlled study, the effect of the antimicrobial treatment (amoxicillin-clavulanate) is examined in children with pathogenic bacteria (S. pneumoniae, H. influenzae or M. catarrhalis) in the nasal middle meatus during respiratory infection. The duration of the symptoms and speed of recovery is recognized by daily symptom-diary, the results are compared between the treatment groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | placebo | mixture, 0.28125 ml/kg twice a day for 7 days |
| DRUG | amoxicillin clavulanate acid | mixture 0.28125 ml / kg twice a day for 7 days |
Timeline
- Start date
- 2007-11-01
- Completion
- 2009-12-01
- First posted
- 2007-10-18
- Last updated
- 2007-10-19
Locations
3 sites across 1 country: Finland
Source: ClinicalTrials.gov record NCT00545961. Inclusion in this directory is not an endorsement.